Analystreport

Correvio Pharma Corp (NASDAQ: CORV) is now covered by analysts at B. Riley. They set a "buy" rating and a $7.00 price target on the stock.

CORREVIO PHARMA CORP ORDINARY SHARES  (CORV) 
Last correvio pharma corp ordinary shares earnings: 11/14 07:00 am Check Earnings Report